Scientific Breakthrough
Tirzepatide represents a revolutionary advancement in weight loss medicine. Understanding how it works helps you appreciate why results are so remarkable.
The Mechanism
Unlike single-action medications, Tirzepatide activates both GIP and GLP-1 receptors simultaneously.
GLP-1 Receptor
GLP-1 (glucagon-like peptide-1) is a hormone naturally produced in your gut after eating. When Tirzepatide activates GLP-1 receptors:
GIP Receptor
GIP (glucose-dependent insulinotropic polypeptide) is another gut hormone that Tirzepatide uniquely activates:
The Synergy
Clinical Research Summary
Clinical Evidence
significant
Average Weight Loss
Participants experienced significant body weight reduction in clinical studies
89%
Achieved 5%+ Loss
Nearly 9 in 10 participants achieved clinically significant weight loss
63%
Achieved 20%+ Loss
More than half achieved weight loss previously only seen with surgery
*Results from published clinical research on dual-agonist therapy
Administration
Tirzepatide is administered via a simple subcutaneous injection once per week. The pre-filled pen makes self-injection easy and virtually painless.
Dosing Schedule
Gradual dose increase minimizes side effects and optimizes results.
Ready to Begin?
Our team will guide you through every step of your Tirzepatide journey.